Suspension of trading
Acorda Therapeutics Stock OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 24-08-13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 24-08-07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% |
| 1 week | 0 |  | 0.02 |
| 1 month | 0 | | 0.15 |
| 3 years | 0 | | 99.8 |
| 5 years | 0 | | 535.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Ali
COO | Chief Operating Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -10.00% | -99.92% | -99.98% | 16.77K | |
| -0.29% | +0.13% | +57.11% | +108.06% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.96B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.12B | |
| -2.91% | +0.27% | +13.28% | -36.73% | 16.31B | |
| -1.21% | -2.11% | +6.92% | -41.11% | 15.19B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.32B | |
| +1.48% | +9.81% | +19.29% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| Average | -0.37% | +2.75% | +15.00% | +80.98% | 23.54B | |
| Weighted average by Cap. | -0.38% | +2.86% | +32.09% | +95.18% |
Employees
-
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
Select your edition
All financial news and data tailored to specific country editions
